Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
29 June 2024
28 June 2024
| m 19:14 | Non-small cell lung cancer, EGFR-mutated diffhist -80 Jwarner talk contribs | ||||
| m 19:07 | Tutorial diffhist -200 Jwarner talk contribs | ||||
|
|
m 17:54 | Non-small cell lung cancer 2 changes history -527 [Warner-admin; Jwarner] | |||
| m |
|
17:54 (cur | prev) -529 Jwarner talk contribs | |||
| m |
|
17:33 (cur | prev) +2 Warner-admin talk contribs Text replacement - "http://ar.iiarjournals.org" to "https://ar.iiarjournals.org" | |||
| m 17:33 | Non-small cell lung cancer - historical diffhist +2 Warner-admin talk contribs Text replacement - "http://ar.iiarjournals.org" to "https://ar.iiarjournals.org" | ||||
27 June 2024
| m 21:36 | Levels of Evidence diffhist -10 Jwarner talk contribs | ||||
| m 20:22 | Complex multipart regimens diffhist -18 Jwarner talk contribs | ||||
26 June 2024
| m 12:19 | Complex multipart regimens diffhist -2 Warner-admin talk contribs Text replacement - "http://www.bloodjournal.org/content/115/6/1113" to "https://doi.org/10.1182/blood-2009-05-222539" | ||||
23 June 2024
| m 12:20 | Non-small cell lung cancer diffhist -35 Jwarner talk contribs | ||||
| m 12:20 | Stub diffhist +248 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) & Veliparib | ||||
| m 12:19 | Non-small cell lung cancer - historical diffhist -1,605 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) & Vadimezan | ||||
22 June 2024
| m 02:22 | Non-small cell lung cancer diffhist +131 Jwarner talk contribs →Cisplatin & Etoposide (EP) {{#subobject:gocg67|Regimen=1}} | ||||
18 June 2024
|
|
m 10:54 | Pembrolizumab (Keytruda) 2 changes history +220 [Jwarner (2×)] | |||
| m |
|
10:54 (cur | prev) -2 Jwarner talk contribs | |||
| m |
|
10:53 (cur | prev) +222 Jwarner talk contribs →Endometrial cancer | |||
15 June 2024
| m 09:33 | Stub diffhist -3 Jwarner talk contribs →ddFEC | ||||
|
|
m 00:29 | Durvalumab (Imfinzi) 3 changes history +314 [Jwarner (3×)] | |||
| m |
|
00:29 (cur | prev) 0 Jwarner talk contribs | |||
| m |
|
00:27 (cur | prev) +53 Jwarner talk contribs | |||
| m |
|
00:25 (cur | prev) +261 Jwarner talk contribs →History of changes in FDA indication | |||
11 June 2024
| m 14:34 | Gefitinib (Iressa) diffhist +9 Jwarner talk contribs →Also known as | ||||
|
|
m 14:23 | Erlotinib (Tarceva) 7 changes history +65 [Jwarner (7×)] | |||
| m |
|
14:23 (cur | prev) +9 Jwarner talk contribs →Also known as | |||
| m |
|
14:23 (cur | prev) +10 Jwarner talk contribs →Also known as | |||
| m |
|
14:23 (cur | prev) +11 Jwarner talk contribs →Also known as | |||
| m |
|
14:22 (cur | prev) +10 Jwarner talk contribs →Also known as | |||
| m |
|
14:22 (cur | prev) +8 Jwarner talk contribs →Also known as | |||
| m |
|
14:21 (cur | prev) +8 Jwarner talk contribs →Also known as | |||
| m |
|
14:21 (cur | prev) +9 Jwarner talk contribs →Also known as | |||
4 June 2024
2 June 2024
1 June 2024
| m 04:03 | Nivolumab (Opdivo) diffhist +210 Jwarner talk contribs →Malignant pleural mesothelioma | ||||
| m 03:50 | Pembrolizumab (Keytruda) diffhist +203 Jwarner talk contribs →Renal cell carcinoma | ||||
|
|
m 03:26 | Stub 2 changes history +16,468 [Jwarner (2×)] | |||
| m |
|
03:26 (cur | prev) +504 Jwarner talk contribs →Regimens that contain experimental (unapproved) drugs | |||
| m |
|
03:25 (cur | prev) +15,964 Jwarner talk contribs →Regimens composed solely of approved drugs | |||